Organization
Zurich University Hospital, Zurich, Switzerland
1 abstract
Abstract
ANTI-CENTROMERE ANTIBODY ISOTYPE LEVELS AS BIOMARKER FOR DISEASE PROGRESSION IN SUBJECTS AT RISK TO DEVELOP SYSTEMIC SCLEROSISOrg: Leiden University Medical Center (LUMC), Leiden, Netherlands, Zurich University Hospital, Zurich, Switzerland, Oslo University Hospital, Oslo, Norway, Ghent University Hospital, Ghent, Belgium, Bordeaux University Hospital, Bordeaux, France,